咽喉和吞嚥障礙市場規模、佔有率和成長分析:按治療方法、病因/病因、最終用戶和地區分類-產業預測,2026-2033年
市場調查報告書
商品編碼
2003730

咽喉和吞嚥障礙市場規模、佔有率和成長分析:按治療方法、病因/病因、最終用戶和地區分類-產業預測,2026-2033年

Pharyngeal Dysphagia Market Size, Share, and Growth Analysis, By Therapeutic Modality (Neuromuscular Electrical Stimulation, Speech & Swallowing Therapy Devices), By Etiology/Cause, By End-User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球咽喉和吞嚥障礙市場價值為 15 億美元,預計將從 2025 年的 16 億美元成長到 2033 年的 27.3 億美元,在預測期(2026-2033 年)內複合年成長率為 6.9%。

全球咽部吞嚥困難市場受到人口老化和影響吞嚥功能的神經系統疾病盛行率的顯著影響,導致對診斷和治療方案的需求不斷成長。咽部吞嚥困難是指吞嚥過程中的障礙,如不及時治療,可能導致嚴重的健康問題,從而增加醫療成本。市場正從傳統的床邊檢查轉向先進的診斷技術,例如螢光吞嚥造影檢查。技術進步,特別是人工智慧(AI)領域的技術進步,透過自動化分析和非侵入性監測,正在改善咽部吞嚥困難的診斷和治療,從而促進臨床醫生的採納和保險公司的支持。此外,監管獎勵和打包支付模式的出現正在推動對創新康復工具的投資,為能夠證明臨床有效性和成本效益的醫療設備製造商創造了盈利機會。

全球咽喉和吞嚥障礙市場促進因素

咽喉和吞嚥障礙的日益普遍,促使人們對更完善的評估、管理和長期照護方案的需求不斷成長,也促使醫療服務提供者和醫療設備製造商不斷創新並豐富其產品種類。隨著需要綜合性、多學科介入的患者數量不斷增加,吞嚥復健計畫、影像技術和輔助器具的使用量也隨之激增。這一趨勢加速了專業產品和培訓服務的開發,以滿足這些需求。為此,保險公司和政策制定者將有效的護理路徑列為優先事項,這反過來又鼓勵製造商拓展其分銷網路和支援服務,最終促進市場成長,並推動包括診斷、治療和輔助技術在內的各個領域的創新。

全球咽喉和吞嚥障礙市場的限制因素

全球咽喉和吞嚥障礙市場面臨諸多限制因素,阻礙了其成長潛力。專業設備、大規模復健計畫和詳盡的診斷流程等相關費用高昂,可能限制病患就醫,並約束醫療機構的採購決策。這些因素導致市場發展放緩。此外,報銷機制的不確定性以及不同支付方覆蓋範圍的不一致性,也為臨床醫生開立先進治療方案和醫院採用新技術帶來了挑戰。這降低了製造商拓展產品線的商業性獎勵。因此,不同醫療機構的採用率存在差異,醫療機構傾向於選擇更具成本效益的解決方案,最終導致需求下降,阻礙了整體市場成長。

全球咽喉和吞嚥障礙市場趨勢

由於遠距復健和遠距醫療解決方案的興起,全球咽喉和吞嚥障礙市場正經歷重大變革。這一趨勢使得患者更容易在傳統臨床環境之外接受治療,並透過虛擬平台和看護者主導的通訊協定實現個人化吞嚥治療。隨著保險公司和醫療服務提供者逐漸認知到結合面對面評估和遠距追蹤的混合護理模式的有效性,他們越來越重視服務創新和專業培訓。這種轉變不僅將減輕患者的通勤負擔,還將促進治療依從性的提高和以患者為中心的治療效果,最終重塑咽喉和吞嚥障礙的整個管理模式。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球咽喉和吞嚥障礙市場規模:依治療方法分類

  • 神經肌肉電刺激(NMES)
  • 言語和吞嚥治療設備
  • 食品增稠劑
  • 手術介入

全球咽喉和吞嚥障礙市場規模:依病因/病因分類

  • 神經質
  • 結構
  • 與老齡化相關的肌少症

全球咽喉和吞嚥障礙市場規模:依最終用戶分類。

  • 復健診所
  • 長期照護機構
  • 家庭醫療保健設施
  • 急診醫院

全球咽喉和吞嚥障礙市場規模:按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要企業2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析,2025 年
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較(2023-2025 年)

主要企業簡介

  • Nestle Health Science
  • Danone
  • Cook Medical
  • Boston Scientific
  • Halyard Health
  • Medtronic
  • Olympus Corporation
  • Smiths Medical
  • CR Bard
  • Abbott Laboratories
  • Cardinal Health
  • Fresenius Kabi
  • Kent Precision Foods
  • Flavor Creations
  • Thick-It
  • SimplyThick
  • Phagenesis
  • VitalStim
  • Passy-Muir
  • Bracco Imaging

結論與建議

簡介目錄
Product Code: SQMIG35A3296

Global Pharyngeal Dysphagia Market size was valued at USD 1.5 Billion in 2024 and is poised to grow from USD 1.6 Billion in 2025 to USD 2.73 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global pharyngeal dysphagia market is significantly influenced by the aging population and the prevalence of neurological conditions that affect swallowing capabilities, leading to an increased demand for both diagnostic and therapeutic solutions. Pharyngeal dysphagia involves difficulties during the swallowing process, with untreated cases potentially resulting in serious health issues, thereby elevating healthcare costs. The market has shifted from traditional bedside examinations to advanced diagnostic techniques such as videofluoroscopic swallow studies. Technological advancements, particularly in artificial intelligence, enhance the diagnosis and management of pharyngeal dysphagia through automated analysis and noninvasive monitoring, fostering clinician adoption and payer support. Furthermore, regulatory incentives and the emergence of bundled payment models are driving investment in innovative rehabilitative tools, presenting lucrative opportunities for device manufacturers that can demonstrate clinical effectiveness and cost efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharyngeal Dysphagia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharyngeal Dysphagia Market Segments Analysis

Global pharyngeal dysphagia market is segmented by therapeutic modality, etiology/cause, end-user and region. Based on therapeutic modality, the market is segmented into Neuromuscular Electrical Stimulation (NMES), Speech & Swallowing Therapy Devices, Dietary Thickening Agents and Surgical Intervention. Based on etiology/cause, the market is segmented into Neurological, Structural and Age-related Sarcopenia. Based on end-user, the market is segmented into Rehabilitation Clinics, Long-term Care Facilities, Home Healthcare Settings and Acute Care Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharyngeal Dysphagia Market

The rising incidence of pharyngeal dysphagia is driving the need for enhanced assessment, management, and long-term care solutions, prompting healthcare providers and device manufacturers to innovate and diversify their offerings. As an increasing number of patients require comprehensive, multidisciplinary interventions, there is a surge in the adoption of swallow rehabilitation programs, imaging technology, and assistive devices. This trend stimulates the creation of specialized products and training services to support these needs. In response, payers and policymakers are prioritizing effective care pathways, which encourages manufacturers to expand their distribution networks and support services, ultimately fostering market growth and driving innovation across various domains such as diagnostics, therapeutics, and supportive technologies.

Restraints in the Global Pharyngeal Dysphagia Market

The Global Pharyngeal Dysphagia market faces several restraints that hinder its growth potential. High expenses related to specialized devices, extensive rehabilitation programs, and thorough diagnostic processes can restrict patient access and limit institutional purchasing decisions. These factors contribute to a slowdown in market development. Additionally, uncertainties surrounding reimbursement frameworks and inconsistencies in payer coverage present challenges for clinicians in prescribing advanced treatments and for hospitals in integrating new technologies. This leads to reduced commercial incentives for manufacturers to broaden their product offerings. Consequently, adoption rates remain inconsistent across different care environments, prompting providers to lean towards more cost-effective solutions, ultimately dampening demand and impeding overall market growth.

Market Trends of the Global Pharyngeal Dysphagia Market

The Global Pharyngeal Dysphagia market is undergoing a significant transformation driven by the rise of tele-rehabilitation and remote care solutions. This trend enhances patient access to therapy outside traditional clinical settings, allowing for individualized swallowing therapy through virtual platforms and caregiver-guided protocols. As payers and providers recognize the efficacy of hybrid care models that combine in-person assessments with remote follow-ups, there is an increased focus on service innovation and professional training. This shift not only alleviates travel burdens for patients but also fosters better adherence and improved patient-centered outcomes, ultimately reshaping the approach to managing pharyngeal dysphagia.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Pharyngeal Dysphagia Market Size by Therapeutic Modality & CAGR (2026-2033)

  • Market Overview
  • Neuromuscular Electrical Stimulation (NMES)
  • Speech & Swallowing Therapy Devices
  • Dietary Thickening Agents
  • Surgical Intervention

Global Pharyngeal Dysphagia Market Size by Etiology/Cause & CAGR (2026-2033)

  • Market Overview
  • Neurological
  • Structural
  • Age-related Sarcopenia

Global Pharyngeal Dysphagia Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Rehabilitation Clinics
  • Long-term Care Facilities
  • Home Healthcare Settings
  • Acute Care Hospitals

Global Pharyngeal Dysphagia Market Size & CAGR (2026-2033)

  • North America (Therapeutic Modality, Etiology/Cause, End-User)
    • US
    • Canada
  • Europe (Therapeutic Modality, Etiology/Cause, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Therapeutic Modality, Etiology/Cause, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Therapeutic Modality, Etiology/Cause, End-User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Therapeutic Modality, Etiology/Cause, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Nestle Health Science
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danone
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Halyard Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Olympus Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • C.R. Bard
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kent Precision Foods
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Flavor Creations
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thick-It
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SimplyThick
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Phagenesis
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • VitalStim
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Passy-Muir
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bracco Imaging
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations